Lack of an Association between Passive Smoking and Incidence of Female Breast Cancer in Non-Smokers: Evidence from 10 Prospective Cohort Studies

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Yang, Yuan ^a   Zhang, Fan ^b   Skrip, Laura ^c   Wang, Yang ^b   Liu, Shengchun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ETHNICITY; HUMAN; MENOPAUSE; PASSIVE SMOKING; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TOBACCO SMOKE POLLUTION;

EID: 84885795699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077029     Document Type: Article

References (49)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1): 10-29.
2. DeSantis C, Siegel R, Bandi P, Jemal A, (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61(6): 409-418.
3. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, et al. (2008) Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100(23): 1672-1694.
4. el-Bayoumy K, (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 5(5): 585-590.
5. MacMahon B, Trichopoulos D, Cole P, Brown J, (1982) Cigarette smoking and urinary estrogens. N Engl J Med 307(17): 1062-1065.
6. Jensen J, Christiansen C, Rødbro P, (1985) Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 313(16): 973-975.
7. Baron JA, La Vecchia C, Levi F, (1990) The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 162(2): 502-514.
8. Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, et al. (2011) Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 342: d1016.
9. Jee SH, Ohrr H, Kim IS, (1999) Effects of husbands' smoking on the incidence of lung cancer in Korean women. Int J Epidemiol 28(5): 824-828.
10. Nishino Y, Tsubono Y, Tsuji I, Komatsu S, Kanemura S, et al. (2001) Passive smoking at home and cancer risk: a population-based prospective study in Japanese nonsmoking women. Cancer Causes Control 12(9): 797-802.
11. Gram IT, Braaten T, Terry PD, Sasco AJ, Adami HO, et al. (2005) Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14(1): 61-66.
12. Hanaoka T, Yamamoto S, Sobue T, Sasaki S, Tsugane S, (2005) Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Study Group (2005) Active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer 114(2): 317-322.
13. Lin Y, Kikuchi S, Tamakoshi K, Wakai K, Kondo T, et al. (2008) Active smoking, passive smoking, and breast cancer risk: findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Epidemiol 18(2): 77-83.
14. Pirie K, Beral V, Peto R, Roddam A, Reeves G, et al. (2008) Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 37(5): 1069-1079.
15. Reynolds P, Goldberg D, Hurley S, Nelson DO, Largent J, et al. (2009) Passive smoking and risk of breast cancer in the California teachers study. Cancer Epidemiol Biomarkers Prev 18(12): 3389-3398.
16. Chuang SC, Gallo V, Michaud D, Overvad K, Tjønneland A, et al. (2011) Exposure to environmental tobacco smoke in childhood and incidence of cancer in adulthood in never smokers in the European prospective investigation into cancer and nutrition. Cancer Causes Control 22: 487-494.
17. Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB, (2011) Cigarette smoking and the incidence of breast cancer. Arch Intern Med 171(2): 125-133.
18. Glantz SA, Parmley WW, (1995) Passive Smoking and Heart Disease: Mechanisms and Risk. JAMA 273(13): 1047-1053.
19. Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, et al. (2002) Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Stroke 33: 2170-2176.
20. Wartenberg D, Calle EE, Thun MJ, Heath CW, Lally C, et al. (2000) Passive smoking exposure and female breast cancer mortality. J Natl Cancer Inst 92(20): 1666-1673.
21. Delfino RJ, Smith C, West JG, Lin HJ, White E, et al. (2000) Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics 10: 461-469.
22. Egan KM, Stampfer MJ, Hunter D, Hankinson S, Rosner BA, et al. (2002) Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology 13(2): 138-145.
23. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, et al. (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96(1): 29-37.
24. Moher D, Liberati A, Tetzlaff J, (2009) Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7): e1000097.
25. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 2012 Oct 19.
26. Hamling J, Lee P, Weitkunat R, Ambuhl M, (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Statist Med 27: 954-970.
27. Overton, Randall C, (1998) A comparison of fixed-effects and mixed (random-effects) models for meta-analysis tests of moderator variable effects. Psychological Methods 3(3): 354-379.
28. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
29. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
30. Kabat GC, Kim M, Phipps AI, Li CI, Messina CR, et al. (2011) Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 22(5): 775-783.
31. Rushton L, Bagga S, Bevan R, Brown TP, Cherrie JW, et al. (2010) Occupation and cancer in Britain. Br J Cancer 102(9): 1428-1437.
32. Kabat GC, Kim M, Kakani C, Tindle H, Wactawski-Wende J, et al. (2010) Cigarette smoking in relation to risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Am J Epidemiol 172(5): 591-599.
33. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, et al. (2009) Occupation and cancer- follow-up of 15 million people in five Nordic countries. Acta Oncol 48(5): 646-790.
34. Cui Y, Miller AB, Rohan TE, (2006) Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat 100(3): 293-299.
35. Al-Delaimy WK, Cho E, Chen WY, Colditz G, et al. (2004) A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol Biomarkers Prev 13(3): 398-404.
36. Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, et al. (2011) Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control 20(1): e2.
37. Johnson KC, Glantz SA, (2008) Evidence secondhand smoke causes breast cancer in 2005 stronger than for lung cancer in 1986. Prev Med 46(6): 492-496.
38. Lee PN, Hamling J, (2006) Environmental Tobacco Smoke Exposure and Risk of Breast Cancer in Nonsmoking Women: A Review with Meta-Analyses. Inhal Toxicol 18: 1053-1070.
39. Petrakis NL, Gruenke LD, Beelen TC, Castagnoli N, Craig JC, (1978) Nicotine in breast fluid of nonlactating women. Science 199(4326): 303-305.
40. Key TJ, Pike MC, Brown JB, Hermon C, Allen DS, et al. (1996) Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. Br J Cancer 74; 1313-1316.
41. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, et al. (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265(15): 1985-1990.
42. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, et al. (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289(24): 3243-3253.
43. Chen S, Parmigiani G, (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 10 25(11): 1329-1333.
44. Yang Y, Zhang F, Wang Y, Liu S, (2012) CHEK2 1100delC Variant and Breast Cancer Risk in Caucasians: An Updated Meta-analysis Based on 25 Studies with 29 154 Cases and 37 064 Controls. Asian pac j cancer prev 13(7): 3501-3505.
45. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, et al. (2007) Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum Mol Genet 16(15): 1794-1801.
46. Conlon MS, Johnson KC, Bewick MA, Lafrenie RM, Donner A, (2010) Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiol 34(2): 142-149.
47. Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, et al. (2010) NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 123(3): 877-883.
48. Millikan RC, Pittman GS, Newman B, Tse CK, Selmin O, et al. (1998) Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(5): 371-378.
49. Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, et al. (1999) N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8(3): 233-239.